{
  "success": true,
  "sourceFile": "input/Alexion_NCT04573309_Wilsons_SAP.pdf",
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33
  ],
  "modelUsed": "gemini-2.5-pro",
  "sapData": {
    "analysisPopulations": [
      {
        "id": "pop_1",
        "name": "Screened Set",
        "populationType": "Screening",
        "instanceType": "AnalysisPopulation",
        "description": "All participants who signed the informed consent form and were screened for study eligibility. The definition is not explicitly stated in the provided text but is inferred from the section title.",
        "criteria": "Signed informed consent form and screened for eligibility"
      },
      {
        "id": "pop_2",
        "name": "Enrolled Set",
        "populationType": "Enrollment",
        "instanceType": "AnalysisPopulation",
        "description": "All participants who were enrolled into the study. The definition is not explicitly stated in the provided text but is inferred from the section title.",
        "criteria": "Enrolled into the study"
      },
      {
        "id": "pop_3",
        "name": "Full Analysis Set",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "FA",
        "description": "The Full Analysis Set will be defined based on the intent-to-treat (ITT) principle. The specific definition is not provided in the document text as the relevant page is missing.",
        "criteria": "Not specified in the provided document text."
      },
      {
        "id": "pop_4",
        "name": "Per Protocol Set",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "PP",
        "description": "The Per Protocol Set is a subset of the Full Analysis Set who are compliant with the protocol. The specific definition is not provided in the document text as the relevant page is missing.",
        "criteria": "Not specified in the provided document text."
      },
      {
        "id": "pop_5",
        "name": "Safety Set",
        "populationType": "Safety",
        "instanceType": "AnalysisPopulation",
        "description": "The Safety Set includes all participants who received at least one dose of the study drug. The specific definition is not provided in the document text as the relevant page is missing.",
        "criteria": "Received at least one dose of study drug"
      },
      {
        "id": "pop_6",
        "name": "Pharmacokinetic Analysis Set",
        "populationType": "PK",
        "instanceType": "AnalysisPopulation",
        "label": "PK",
        "description": "The Pharmacokinetic Analysis Set includes participants with sufficient data for pharmacokinetic analysis. The specific definition is not provided in the document text as the relevant page is missing.",
        "criteria": "Not specified in the provided document text."
      },
      {
        "id": "pop_7",
        "name": "Pharmacodynamic Analysis Set",
        "populationType": "PD",
        "instanceType": "AnalysisPopulation",
        "label": "PD",
        "description": "The Pharmacodynamic Analysis Set includes participants with sufficient data for pharmacodynamic analysis. The specific definition is not provided in the document text as the relevant page is missing.",
        "criteria": "Not specified in the provided document text."
      }
    ],
    "characteristics": [
      {
        "id": "char_1",
        "name": "Age",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Age of the participant. Mentioned in Section 9.2.2 'Age and Dates'."
      },
      {
        "id": "char_2",
        "name": "Sex",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Sex of the participant. Inferred from Section 7.1.3.1 'Demographics'."
      },
      {
        "id": "char_3",
        "name": "Race",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Race of the participant. Inferred from Section 7.1.3.1 'Demographics'."
      },
      {
        "id": "char_4",
        "name": "Ethnicity",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Ethnicity of the participant. Inferred from Section 7.1.3.1 'Demographics'."
      },
      {
        "id": "char_5",
        "name": "Body Mass Index",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Body Mass Index (BMI) at baseline. Mentioned in Section 9.2.5 'Body Mass Index'."
      },
      {
        "id": "char_6",
        "name": "Wilson Disease (WD) history",
        "dataType": "Text",
        "instanceType": "Characteristic",
        "description": "History of Wilson Disease. Mentioned in Section 4.2 and inferred from Section 7.1.3.2 'Baseline Disease Characteristics'."
      },
      {
        "id": "char_7",
        "name": "Medical/Surgical History",
        "dataType": "Text",
        "instanceType": "Characteristic",
        "description": "Participant's medical and surgical history. From Section 7.1.3.3 'Medical/Surgical History'."
      },
      {
        "id": "char_8",
        "name": "Prior medications used to treat Wilson Disease",
        "dataType": "Text",
        "instanceType": "Characteristic",
        "description": "Prior medications specifically used for the treatment of Wilson Disease. Mentioned in Section 4.2 and Section 7.1.4 'Prior and Concomitant Medications/Therapies'."
      },
      {
        "id": "char_9",
        "name": "Concomitant Medications/Therapies",
        "dataType": "Text",
        "instanceType": "Characteristic",
        "description": "Medications and therapies taken by the participant during the study. From Section 7.1.4 'Prior and Concomitant Medications/Therapies'."
      },
      {
        "id": "char_10",
        "name": "Baseline copper balance",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Pretreatment copper balance measured during the Run-in Period (Day -4 through Day -1)."
      },
      {
        "id": "char_11",
        "name": "Baseline molybdenum balance",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Pretreatment molybdenum balance measured during the Run-in Period (Day -4 through Day -1)."
      }
    ],
    "summary": {
      "populationCount": 7,
      "characteristicCount": 11
    }
  }
}